Centene Corporation (CNC) Stock Price

CNCStock

$65.00+123.22%52W

Market Cap$32.11B

P/E—

PEG Ratio0.88

Div yield—

Beta1.12

CNC Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)41.18%

Price vs S&P 500 (4W)-0.33%

PEG Ratio0.88

VGM Score74.15

P/CF (Annual)6.64x

Book Value / Share (Quarterly)$45.67

P/TBV (Annual)1.31x

Revenue Growth (3Y)10.45%

Cash Flow / Share (Quarterly)$17.69

Price vs S&P 500 (YTD)47.58%

Gross Margin (TTM)7.18%

Net Profit Margin (TTM)-3.25%

EPS (TTM)$-10.44

10-Day Avg Trading Volume3.12M

EPS Excl Extra (TTM)$-10.44

Revenue Growth (5Y)24.47%

EPS (Annual)$-13.53

ROI (Annual)-17.87%

Gross Margin (Annual)7.12%

Net Profit Margin (5Y Avg)0.45%

Cash / Share (Quarterly)$48.08

Revenue Growth QoQ (YoY)7.13%

ROA (Last FY)-8.70%

Revenue Growth TTM (YoY)17.02%

EBITD / Share (TTM)$-8.89

ROE (5Y Avg)-0.09%

Operating Margin (TTM)-3.68%

Cash Flow / Share (Annual)$8.51

P/B Ratio1.46x

P/B Ratio (Quarterly)1.40x

Net Income / Employee (Annual)$-109,200

EV / Revenue (TTM)0.13x

Net Interest Coverage (TTM)-8.92x

ROA (TTM)-6.32%

EPS Growth QoQ (YoY)18.16%

EV / EBITDA (TTM)7.83x

EPS Incl Extra (Annual)$-13.53

Current Ratio (Annual)1.10x

Quick Ratio (Quarterly)1.12x

3-Month Avg Trading Volume5.44M

52-Week Price Return123.22%

EV / Free Cash Flow (Annual)5.94x

Revenue / Employee (TTM)$3,242,200

Tangible BV / Share (Quarterly)$37.16

P/S Ratio (Annual)0.17x

Asset Turnover (Annual)2.54x

52-Week High$69.36

Operating Margin (5Y Avg)0.50%

EPS Excl Extra (Annual)$-13.53

CapEx CAGR (5Y)-2.47%

Tangible BV CAGR (5Y)-2.37%

26-Week Price Return52.43%

Quick Ratio (Annual)1.10x

13-Week Price Return13.64%

Total Debt / Equity (Annual)0.87x

Current Ratio (Quarterly)1.12x

Enterprise Value$24.84B

Revenue / Share Growth (5Y)12.65%

Asset Turnover (TTM)2.43x

Book Value / Share Growth (5Y)-1.77%

Revenue / Employee (Annual)$3,187,800

Pretax Margin (Annual)-3.45%

Cash / Share (Annual)$41.32

3-Month Return Std Dev40.42%

Gross Margin (5Y Avg)10.29%

Net Income / Employee (TTM)$-83,500

EBITDA Interim CAGR (5Y)11.22%

ROE (Last FY)-33.45%

Net Interest Coverage (Annual)-6.07x

EPS Basic Excl Extra (Annual)$-13.53

P/FCF (TTM)3.76x

Receivables Turnover (TTM)9.46x

EV / Free Cash Flow (TTM)2.84x

Total Debt / Equity (Quarterly)0.71x

EPS Incl Extra (TTM)$-10.44

Receivables Turnover (Annual)10.30x

ROI (TTM)-13.39%

P/S Ratio (TTM)0.17x

Pretax Margin (5Y Avg)0.86%

Revenue / Share (Annual)$394.99

Tangible BV / Share (Annual)$31.36

Forward P/E13.59x

Free OCF CAGR (5Y)-2.03%

Price vs S&P 500 (52W)104.91%

Year-to-Date Return59.54%

5-Day Price Return0.66%

EPS Normalized (Annual)$-13.53

ROA (5Y Avg)0.36%

Net Profit Margin (Annual)-3.43%

Month-to-Date Return5.51%

Cash Flow / Share (TTM)$6.92

EBITD / Share (Annual)$-12.87

Operating Margin (Annual)-3.91%

LT Debt / Equity (Annual)0.87x

P/CF (TTM)3.45x

ROI (5Y Avg)0.30%

LT Debt / Equity (Quarterly)0.71x

EPS Basic Excl Extra (TTM)$-10.44

P/TBV (Quarterly)1.73x

P/B Ratio (Annual)1.01x

Pretax Margin (TTM)-3.22%

Book Value / Share (Annual)$40.57

Price vs S&P 500 (13W)10.85%

Net Margin Growth (5Y)-10.04%

Beta1.12x

P/FCF (Annual)7.86x

Revenue / Share (TTM)$399.73

ROE (TTM)-24.03%

52-Week Low$28.24

vGradeB

gGradeC

mGradeA

vgmGradeB

CNC Earnings Surprise History

Q2 25-0.16est. 0.21

Q3 250.50est. -0.16

Q4 25-1.19est. -1.22

Q1 263.37est. 2.13

Q2 262.51est. 1.08

CNC Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

3.50

3.54

3.52

Industry Peers — Hospital & Medical Insurance(9)

Symbol	Value Score	Growth Score	Momentum Score	Price
CNCCentene Corporation	B	C	A	$65.00
UNHUNITEDHEALTH GROUP INCORPORATED (Delaware)	D	D	B	$396.59
ELVElevance Health, Inc.	D	D	C	$398.87
CIThe Cigna Group	B	C	D	$279.32
HUMHumana Inc.	D	D	A	$389.71
MOHMolina Healthcare, Inc.	D	D	C	$199.63
OSCROscar Health, Inc.	B	A	A	$30.93
ALHCAlignment Healthcare, Inc. Common Stock	D	A	F	$13.59
CLOVClover Health Investments, Corp	D	A	B	$4.13
TRUPTrupanion, Inc.	D	B	C	$31.84

About Centene Corporation

Centene Corporation is a managed care organization serving 22 million members through government-sponsored health plans, with revenue diversified across Medicaid (approximately 60% of membership), individual exchange plans (20%), Medicare, and military contracts. The company also provides Medicare Part D pharmaceutical coverage. As a leading platform in government-sponsored healthcare, Centene benefits from stable government reimbursement and recurring membership revenue.